Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common and female-specific roles of protein tyrosine phosphatase receptors N and N2 in mice reproduction. | Sci Rep | 2023 | 36611058 | PubTator, text mining | PubMed |
| Gender gaps in type 1 diabetes care. | Acta Diabetol | 2023 | 36592220 | PubTator, text mining | PubMed |
| Affinity purification of serum-derived anti-IA-2 autoantibodies in type 1 diabetes using a novel MBP-IA-2 fusion protein. | Biochem Biophys Rep | 2023 | 36578528 | PubTator, text mining | PubMed |
| Recent advances in characterization of citrullination and its implication in human disease research: From method development to network integration. | Proteomics | 2023 | 36546832 | PubTator, text mining | PubMed |
| The complement system and human autoimmune diseases. | J Autoimmun | 2023 | 36535812 | PubTator, text mining | PubMed |
| Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study. | Nat Med | 2023 | 36477733 | PubTator, text mining | PubMed |
| Pathologically noninvasive cancer predictors and surgical procedure for peripheral lung cancer. | Thorac Cancer | 2023 | 36416051 | PubTator, text mining | PubMed |
| Harnessing the synergy of perfusable muscle flap matrix and adipose-derived stem cells for prevascularization and macrophage polarization to reconstruct volumetric muscle loss. | Bioact Mater | 2023 | 36382023 | PubTator, text mining | PubMed |
| Type 1 diabetes mellitus after cord blood transplantation from an unrelated donor with a disease-sensitive haplotype. | J Diabetes Investig | 2023 | 36321643 | PubTator, text mining | PubMed |
| Type 1 diabetes recurrence after SARS-CoV-2 infection in a subject with pancreas transplantation. | Endocrinol Diabetes Metab | 2023 | 36307982 | PubTator, text mining | PubMed |
| Clinical signs of type 1 diabetes are associated with type 2 diabetes marker transcription factor 7-like 2 polymorphism. | J Diabetes Investig | 2023 | 36300877 | PubTator, text mining | PubMed |
| Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma. | Intern Med | 2023 | 36288990 | PubTator, text mining | PubMed |
| Metabolic signatures of β-cell destruction in type 1 diabetes. | J Diabetes Investig | 2023 | 36227003 | PubTator, text mining | PubMed |
Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes. | J Diabetes Investig | 2023 | 36177861 | PubTator, text mining | PubMed |
| Clinical Utility and Outcome Prediction of Early ZnT8-IgG Testing and Titer in Type 1 Diabetes | J Clin Res Pediatr Endocrinol | 2023 | 35984226 | PubTator, text mining | PubMed |
| Revisiting transplant immunology through the lens of single-cell technologies. | Semin Immunopathol | 2023 | 35980400 | PubTator, text mining | PubMed |
| Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies. | Diabetologia | 2023 | 35867129 | PubTator, text mining | PubMed |
| Sorting nexins: role in the regulation of blood pressure. | FEBS J | 2023 | 34847291 | PubTator, text mining | PubMed |
| Serum IL-1ra Is Associated with but Has No Genetic Link to Type 1 Diabetes. | Endocrines | 2022 | 40855874 | PubTator, text mining | PubMed |
| Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022. | Obes Pillars | 2022 | 37990723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=18